Oral Contraceptives Are a Risk Factor for Cerebral Vein Thrombosis

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Download PDF

Thromb Haemost 1996; 76(03): 477-478
DOI: 10.1055/s-0038-1650604

Letters to the Editor

Schattauer GmbH Stuttgart

I Martinelli

¹The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy

,

F R Rosendaal

²The Dept of Clinical Epidemiology, Leiden University Hospital, Leiden, The Netherlands

,

J P Vandenbroucke

²The Dept of Clinical Epidemiology, Leiden University Hospital, Leiden, The Netherlands

,

P M Mannucci

¹The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy

Further Information

Received 29 May 1996

Accepted 30 May 1996

Publication Date:
10 July 2018 (online)

References
1 Martinelli I, Landi G, Merati G, Celia E, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral vein thrombosis. Thromb Haemost 1996; 75: 393-394

Thieme Connect PubMed Search in Google Scholar
2 Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaalb FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457

Crossref PubMed Search in Google Scholar
3 Rosendaal FR. Oral contraceptives and screening for factor V Leiden. Thromb Haemost 1996; 75: 524-525

Thieme Connect PubMed Search in Google Scholar